The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.
Open accessAbstract
We have recently cloned the human fms-like tyrosine kinase 4 gene FLT4, whose protein product is related to two vascular endothelial growth factor receptors FLT1 and KDR/FLK1. Here the expression of FLT4 has been analyzed by in situ hybridization during mouse embryogenesis and in adult human tissues. The FLT4 mRNA signals first became detectable in the angioblasts of head mesenchyme, the cardinal vein, and extraembryonally in the allantois of 8.5-day postcoitus (p.c.) embryos. In 12.5-day p.c. embryos, the FLT4 signal decorated developing venous and presumptive lymphatic endothelia, but arterial endothelia were negative. During later stages of development, FLT4 mRNA became restricted to vascular plexuses devoid of red cells, representing developing lymphatic vessels. Only the lymphatic endothelia and some high endothelial venules expressed FLT4 mRNA in adult human tissues. Increased expression occurred in lymphatic sinuses in metastatic lymph nodes and in lymphangioma. Our results suggest that FLT4 is a marker for lymphatic vessels and some high endothelial venules in human adult tissues. They also support the theory on the venous origin of lymphatic vessels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., & Williams, L. T. (1992) · Science · doi:10.1126/science.1312256 · Cited by 2,016
Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P. H., Risau, W., & Ullrich, A. (1993) · Cell · doi:10.1016/0092-8674(93)90573-9 · Cited by 1,927
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., & Böhlen, P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90483-2 · Cited by 1,519
Cattoretti, G., Becker, M. H. G., Key, G., Duchrow, M., Schlüuter, C., Galle, J., & Gerdes, J. (1992) · The Journal of Pathology · doi:10.1002/path.1711680404 · Cited by 1,447
The role of angiogenesis in tumor growth.
Folkman, J. (1992) · PubMed · Cited by 1,259
Klagsbrun, M., & D'Amore, P. A. (1991) · Annual Review of Physiology · doi:10.1146/annurev.ph.53.030191.001245 · Cited by 957
Folkman, J., & Shing, Y. (1992) · PubMed · Cited by 789
Endothelial proliferation in tumours and normal tissues: Continuous labelling studies
Hobson, B., & Denekamp, J. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.66 · Cited by 565
Nucleotide sequence of a full-length cDNA for mouse cytosketetal β-actin raRNA
ToIcunaga, K., Taniguchi, H., Yoda, K., Shimizu, M., & Salciyama, S. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.6.2829 · Cited by 536
Cited by
Items 101–139 of 139
Neuropilin‐1 expression by tumor cells promotes tumor angiogenesis and progression
Miao, H., Lee, P., Lin, H., Soker, S., & Klagsbrun, M. (2000) · The FASEB Journal · doi:10.1096/fj.00-0250com · Cited by 312
Kubo, H., Cao, R., Bräkenhielm, E., Mäkinen, T., Cao, Y., & Alitalo, K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062040199 · Cited by 305
Self-citationPartanen, T. A., Alitalo, K., & Miettinen, M. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991201)86:11<2406::aid-cncr31>3.0.co;2-e · Cited by 304
Self-citationMolecular Cloning of a Novel Vascular Endothelial Growth Factor, VEGF-D
Yamada, Y., Nezu, J.-I., Shimane, M., & Hirata, Y. (1997) · Genomics · doi:10.1006/geno.1997.4774 · Cited by 300
The role of tumor lymphangiogenesis in metastatic spread
STACKER, S. A., BALDWIN, M. E., & ACHEN, M. G. (2002) · The FASEB Journal · doi:10.1096/fj.01-0945rev · Cited by 296
Arterial versus venous endothelial cells
dela Paz, N. G., & D’Amore, P. A. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0706-5 · Cited by 293
Vascular Endothelial Growth Factor D Is Dispensable for Development of the Lymphatic System
Baldwin, M. E., Halford, M. M., Roufail, S., Williams, R. A., Hibbs, M. L., Grail, D., Kubo, H., Stacker, S. A., & Achen, M. G. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2441-2449.2005 · Cited by 289
The Lymphatic System in Health and Disease
Cueni, L. N., & Detmar, M. (2008) · Lymphatic Research and Biology · doi:10.1089/lrb.2008.1008 · Cited by 288
A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy
Hägerling, R., Pollmann, C., Andreas, M., Schmidt, C., Nurmi, H., Adams, R. H., Alitalo, K., Andresen, V., Schulte-Merker, S., & Kiefer, F. (2013) · The EMBO Journal · doi:10.1038/emboj.2012.340 · Cited by 288
Self-citationInterstitial Flow as a Guide for Lymphangiogenesis
Boardman, K. C., & Swartz, M. A. (2003) · Circulation Research · doi:10.1161/01.res.0000065621.69843.49 · Cited by 286
Schledzewski, K., Falkowski, M., Moldenhauer, G., Metharom, P., Kzhyshkowska, J., Ganss, R., Demory, A., Falkowska‐Hansen, B., Kurzen, H., Ugurel, S., et al. (2006) · The Journal of Pathology · doi:10.1002/path.1942 · Cited by 286
Vascular Development in the Zebrafish
Gore, A. V., Monzo, K., Cha, Y. R., Pan, W., & Weinstein, B. M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006684 · Cited by 282
Hereditary lymphedema: evidence for linkage and genetic heterogeneity
Ferrell, R. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.13.2073 · Cited by 282
Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer
Schoppmann, S. F., Bayer, G., Aumayr, K., Taucher, S., Geleff, S., Rudas, M., Kubista, E., Hausmaninger, H., Samonigg, H., Gnant, M., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133355.48672.22 · Cited by 281
Tsurusaki, T., Kanda, S., Sakai, H., Kanetake, H., Saito, Y., Alitalo, K., & Koji, T. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690356 · Cited by 280
Self-citationThe cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction
Vieira, J. M., Norman, S., Villa del Campo, C., Cahill, T. J., Barnette, D. N., Gunadasa-Rohling, M., Johnson, L. A., Greaves, D. R., Carr, C. A., Jackson, D. G., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97192 · Cited by 278
Signaling via Vascular Endothelial Growth Factor Receptors
Petrova, T. V., Makinen, T., & Alitalo, K. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4707 · Cited by 277
Self-citationDose-dependent response of FGF-2 for lymphangiogenesis
Chang, L. K., Garcia-Cardeña, G., Farnebo, F., Fannon, M., Chen, E. J., Butterfield, C., Moses, M. A., Mulligan, R. C., Folkman, J., & Kaipainen, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404272101 · Cited by 276
Self-citationAngiogenesis in Endocrine Tumors
Turner, H. E., Harris, A. L., Melmed, S., & Wass, J. A. H. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0008 · Cited by 275
Morabito, A., De Maio, E., Di Maio, M., Normanno, N., & Perrone, F. (2006) · The Oncologist · doi:10.1634/theoncologist.11-7-753 · Cited by 274
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema
Yoon, Y.-S., Murayama, T., Gravereaux, E., Tkebuchava, T., Silver, M., Curry, C., Wecker, A., Kirchmair, R., Hu, C. S., Kearney, M., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15830 · Cited by 270
VEGF receptor protein–tyrosine kinases: Structure and regulation
Roskoski, R. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.121 · Cited by 269
The β-Chemokine Receptor D6 Is Expressed by Lymphatic Endothelium and a Subset of Vascular Tumors
Nibbs, R. J. B., Kriehuber, E., Ponath, P. D., Parent, D., Qin, S., Campbell, J. D. M., Henderson, A., Kerjaschki, D., Maurer, D., Graham, G. J., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64035-7 · Cited by 268
Inflammation and Lymphatic Function
Schwager, S., & Detmar, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00308 · Cited by 266
Vascular remodeling is governed by a VEGFR3-dependent fluid shear stress set point
Baeyens, N., Nicoli, S., Coon, B. G., Ross, T. D., Van den Dries, K., Han, J., Lauridsen, H. M., Mejean, C. O., Eichmann, A., Thomas, J.-L., et al. (2015) · eLife · doi:10.7554/elife.04645 · Cited by 265
Platelets, Petechiae, and Preservation of the Vascular Wall
Nachman, R. L., & Rafii, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800887 · Cited by 265
Molecular Basis of Angiogenesis: Role of VEGF and VE‐Cadherin
CARMELIET, P., & COLLEN, D. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06320.x · Cited by 264
Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
Saaristo, A., Karpanen, T., & Alitalo, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203969 · Cited by 264
Self-citationNonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision
Cursiefen, C., Chen, L., Saint-Geniez, M., Hamrah, P., Jin, Y., Rashid, S., Pytowski, B., Persaud, K., Wu, Y., Streilein, J. W., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506112103 · Cited by 262
Aird, W. C., Edelberg, J. M., Weiler-Guettler, H., Simmons, W. W., Smith, T. W., & Rosenberg, R. D. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.5.1117 · Cited by 260
Therapeutic lymphangiogenesis with human recombinant VEGF‐C
Szuba, A., Skobe, M., Karkkainen, M. J., Shin, W. S., Beynet, D. P., Rockson, N. B., Dakhil, N., Spilman, S., Goris, M. L., Strauss, H. W., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0401fje · Cited by 260
Self-citationMolecular Control of Lymphatic Metastasis
Achen, M. G., & Stacker, S. A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1413.020 · Cited by 260
Gong, M. M., Lugo-Cintron, K. M., White, B. R., Kerr, S. C., Harari, P. M., & Beebe, D. J. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119225 · Cited by 87
Molecular mechanisms of lymphangiogenesis in development and cancer
Albrecht, I., & Christofori, G. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103226ia · Cited by 79
“5 VEGFR3 expression becomes restricted to LEC (Kaipainen et al., 1995), when defective VEFGR3 signaling interferes with the development of a proper lymphatic vasculature.”
BackgroundLohela, M., Heloterä, H., Haiko, P., Dumont, D. J., & Alitalo, K. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080378 · Cited by 73
Hokari, R., Kitagawa, N., Watanabe, C., Komoto, S., Kurihara, C., Okada, Y., Kawaguchi, A., Nagao, S., Hibi, T., & Miura, S. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05225.x · Cited by 70
Hsu, M.-C., Pan, M.-R., & Hung, W.-C. (2019) · Cells · doi:10.3390/cells8030270 · Cited by 67
Shaping of Peripheral T Cell Responses by Lymphatic Endothelial Cells
Humbert, M., Hugues, S., & Dubrot, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00684 · Cited by 32
“However, it is also expressed by angioblasts and developing veins during embryonic development (8, 10, 11).”
BackgroundInfluentialLymphatic Capillaries in Aging
Jakic, B., Kerjaschki, D., & Wick, G. (2020) · Gerontology · doi:10.1159/000508459 · Cited by 28
Metadata
- Authors
- Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W., Fang, G. H., Dumont, D., Breitman, M., & Alitalo, K.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-04-11
- Volume
- 92
- Issue
- 8
- Pages
- 3566-3570
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2025173623
- Cited by
- 1,423
- References
- 26
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.